Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study.

Gu T, Chen Y, Zhang N, Alam U, Proietti R, Liu T, Chen KY, Lip GYH

Open source

DOI
10.1002/bcp.70687
Published
2026 Jul 7
Container
British journal of clinical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/bcp.70687,
  title = {Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study.},
  author = {Gu T and Chen Y and Zhang N and Alam U and Proietti R and Liu T and Chen KY and Lip GYH},
  year = {2026},
  journal = {British journal of clinical pharmacology},
  doi = {10.1002/bcp.70687},
  url = {https://doi.org/10.1002/bcp.70687}
}

RIS

TY  - JOUR
TI  - Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study.
AU  - Gu T
AU  - Chen Y
AU  - Zhang N
AU  - Alam U
AU  - Proietti R
AU  - Liu T
AU  - Chen KY
AU  - Lip GYH
PY  - 2026
JO  - British journal of clinical pharmacology
DO  - 10.1002/bcp.70687
UR  - https://doi.org/10.1002/bcp.70687
ER  - 

APA

T, G., Y, C., N, Z., U, A., R, P., T, L., KY, C., & GYH, L. (2026). Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study.. British journal of clinical pharmacology. https://doi.org/10.1002/bcp.70687

Source records